Late-onset psoriatic arthritis: are there any distinct characteristics? A retrospective cohort data analysis

Gialouri, C. G., Evangelatos, G., Iliopoulos, A., Tektonidou, M. G., Sfikakis, P. P., Fragoulis, G. E. and Nikiphorou, E. (2023) Late-onset psoriatic arthritis: are there any distinct characteristics? A retrospective cohort data analysis. Life, 13(3), 792. (doi: 10.3390/life13030792) (PMID:36983947) (PMCID:PMC10058512)

[img] Text
295011.pdf - Published Version
Available under License Creative Commons Attribution.

269kB

Abstract

As life expectancy increases, psoriatic arthritis (PsA) in older individuals becomes more prevalent. We explored whether late-onset versus earlier-onset PsA patients display different clinical features at diagnosis and/or during the disease course, as well as different treatment approaches and comorbidity profiles. We retrospectively collected data from consecutive PsA patients attending two rheumatology centers (December 2017–December 2022). Late-onset PsA patients (diagnosis-age: ≥60 years) were compared to those diagnosed before 60 years old. Univariate analyses and logistic regression were performed to examine for factors associated with late-onset PsA. For sensitivity analyses, the cohort’s mean diagnosis age was used as the cut-off value. Overall, 281 PsA patients were included (mean ± SD diagnosis-age: 46.0 ± 13.3 years). Of them, 14.2% (N = 40) had late-onset PsA. At diagnosis, after controlling for confounders, no demographic and clinical differences were identified. During the disease course, the late-onset group exhibited 65% fewer odds of manifesting enthesitis (adjusted Odds-ratio—adOR 0.35; 95% confidence interval 0.13–0.97), but higher frequency of dyslipidemia (adOR 3.01; 1.30–6.95) and of major adverse cardiovascular events (adOR 4.30; 1.42–12.98) compared to earlier-onset PsA group. No differences were found in the treatment approaches. In sensitivity analyses, PsA patients diagnosed after 46 (vs. ≤46) years old had an increased frequency of hypertension (adOR 3.18; 1.70–5.94) and dyslipidemia (adOR 2.17; 1.25–3.74). The present study underpins that late-onset PsA is not uncommon, while the age at PsA onset may affect the longitudinal clinical expression of the disease. Patients with late-onset PsA were less likely to manifest enthesitis but displayed increased cardiovascular risk.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Fragkoulis, Dr Georgios
Creator Roles:
Fragoulis, G. E.Conceptualization, Methodology, Validation, Formal analysis, Investigation, Resources, Data curation, Writing – review and editing, Supervision
Authors: Gialouri, C. G., Evangelatos, G., Iliopoulos, A., Tektonidou, M. G., Sfikakis, P. P., Fragoulis, G. E., and Nikiphorou, E.
College/School:College of Medical Veterinary and Life Sciences > School of Infection & Immunity
Journal Name:Life
Publisher:MDPI
ISSN:2075-1729
ISSN (Online):2075-1729
Copyright Holders:Copyright © 2023 by the authors
First Published:First published in Life 13(3):792
Publisher Policy:Reproduced under a Creative Commons license

University Staff: Request a correction | Enlighten Editors: Update this record